Benzinga | May 5, 2021 10:32AM EDT

Goldman Sachs Upgrades Xylem to Neutral, Raises Price Target to $107

Goldman Sachs analyst Brian Lee upgrades Xylem (NYSE:XYL) from Sell to Neutral and raises the price target from $73 to $107.